This unique report provides information not available from any other published source, including volume, sales, and leading supplier shares by test.
This comprehensive European survey is designed to assist diagnostics industry executives, as well as companies planning to diversify into the dynamic and rapidly expanding infectious disease testing market, in evaluating emerging opportunities and developing effective business strategies. The report provides market segmentation analysis of over 70 diseases and viruses in five countries, assessment of emerging technologies, review of current instrumentation, as well as strategic profiles of leading suppliers and recent market entrants with innovative technologies and products.
The infectious disease testing market is one of the most rapidly growing segments of the in vitro diagnostics industry, and the greatest challenge facing suppliers in the 21st century. Among the main driving forces behind the growth of this dynamic market is continuous spread of AIDS, which remains the worlds major health threat and a major factor contributing to the rise in incidence of opportunistic infections; bioterrorism; advances in molecular diagnostic technologies; and a wider availability of immunosuppressive drugs.
Although for some infections the etiology is still a mystery, while for others the causative microorganisms are present in minute concentrations long before the occurrence of first clinical symptoms, recent advances in genetic engineering and detection technologies are creating exciting opportunities for highly sensitive, specific and cost-effective products.Contains 1,600 pages and 580 tables
SIMILAR MARKET STUDIES
Complete report $11,500. DataPack (test volumes, sales forecasts, supplier shares) $7,500. Summary This comprehensive report contains 306 pages, 59 tables, and is designed to help current suppliers and potential market entrants identify and evaluate business opportunities emerging in US hematology and flow cytometry hospital, commercial and point-of-care/POC markets during the next ...
October 2015 | $7500 | View Details >>
Complete report $33,500. DataPack (test volumes, sales forecasts, supplier shares) $21,800.This new report from Venture Planning Group contains 1,115 pages, 450 tables and provides forecasts for 100 tests by country and market segment, as well as sales and market sha
January 2014 | $21800 | View Details >>
2016 World Cancer Diagnostics Market Segmentation Analysis: Cancer Clinics, Commercial Labs, Hospitals, Physician Offices-Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains (DataPack)
This DataPack contains tables from VPGMarketResearch.com new report, 2016 World Cancer Diagnostics Market Segmentation Analysis: Cancer Clinics, Commercial Labs, Hospitals, Physician Offices--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains. For pricing information on DataPack sections or individual tables, please contact Customer Service.
February 2016 | $0 | View Details >>
2016 Nucleic Acid Testing: Infectious Diseases, Cancer, Genetic Diseases, Forensic Testing, Paternity Testing/HLA Typing-Technological Breakthroughs, Emerging Tests, Market Forecasts, Competitive Intelligence
This unique seven-country, 1,050-page report is designed to help current suppliers and potential market entrants identify and evaluate major business opportunities emerging in the NAT market during this decade. Highlights- Business and technological trends in seven major markets - Five- and ten-year test volume and sales forecasts- Market shares of ...
October 2015 | $15900 | View Details >>
UPCOMING MARKET RESEARCH REPORTS
2017 © Copyright Big Market Research